FOLFIRI or mFOLFOX6 as Adjuvant Chemotherapy Regiment After Neo-adjuvant Chemotherapy With FOLFIRI in Patients With Advanced Colorectal Cancer: a Randomized, Multicenter Clinical Trial
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
The investigator will follow up all the enrolled patients. The difference of 3-year-DFS between two groups will be compared.
3-year disease-free survival rate
YULONG HE, PhD
First Affiliated Hospital, Sun Yat-Sen University
China: Food and Drug Administration